AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Findings from G. Vetrano et al in colposcopy reported.
Researchers in Rome, Italy conducted a study "To evaluate the recurrence rate of high-grade squamous intraepithelial lesions in postmenopausal women previously submitted to laser CO2 conization and the role of persistent oncogenic HPV types. Fifty-five patients with a cytological diagnosis of high-grade squamous intraepithelial lesions were triaged with a standard colposcopy."
"Hormonal replacement therapy was considered as significative in influencing cervical trophism. Vaginal smears for microbiological examination were obtained. H-R HPV test was performed by PCR. The follow-up checks including cytology, colposcopy and HVP test were performed for a minimum of 5 years. Histological analysis revealed 19 CIN2 (cervical intraepithelial lesions) and 36 CIN3 lesions. The cumulative failure rate at first treatment was 14%. HPV test was positive for HPV 16 type in all patients. Forty-two patients during the follow up checks resulted negative to cytology, colposcopy and HR HPV test. At the one-year follow-up check, 7 patients revealed normal cytological and abnormal colposcopical findings and persistent positive HR HPV test. At the five-year follow-up check, 14 patients with a normal cytological smear had a recurrence of CIN2/3 and positive HR HPV test. In postmenopause, the correct management of H-R squamous intraepithelial lesions is still debated. However, a ...
- Alfacell's ONCONASE Study Results Published In Anticancer Research.
- Press release article from: M2 Presswire March 26, 2007 700+ words
...Watchlist: Alfacell's ONCONASE Study Results Published In Anticancer Research(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:26032007...cell lung cancer (NSCLC) were recently published in Anticancer Research. "ONCONASE has important potential clinical uses for...
- Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate...
- Press release article from: PR Newswire July 1, 2008 700+ words
...response in breast cancer patients treated with neoadjuvant (pre-operative) chemotherapy. Data published in Anticancer Research show that the assay accurately predicted response to therapy 75% of the time. This study, done in conjunction...
- Functional nuclear MRI is applied to in vivo anticancer research.
- Newspaper article from: Drug Week July 2, 2004 700+ words
...of Radiology (The development and application of functional nuclear magnetic resonance to in vivo therapeutic anticancer research. Br J Radiol, 2004;77(916):296-307). For more information, contact A. Dzikjurasz, GlaxoSmithKline...
- In vivo Study Results Demonstrating Potential of Alfacell's ONCONASE(R) for...
- Press release article from: PR Newswire March 26, 2007 700+ words
...ONCONASE (ranpirnase) for the treatment of non-small cell lung cancer (NSCLC) were recently published in Anticancer Research (2007; 27: 299- 308). Based on the work of Intae Lee, Ph.D., at the University of Pennsylvania, a...
- Strawberry fields (funding) forever.(Indications)(anticancer research)(Brief...
- Magazine article from: Family Practice News Kubetin, Sally Koch June 15, 2005 700+ words
Forget your concern that funding from the pharmaceutical industry may influence medical research findings. Now fruit farmers have joined the action, underwriting research into the health benefits of their produce. Specifically, the University of California, Los Angeles, has received a grant from
- Criticare Systems provides update on Immtech's progress in anticancer research;...
- Press release article from: Business Wire December 4, 1995 700+ words
MILWAUKEEBUSINESS WIREDec. 4, 1995--Criticare Systems Inc. (NASDAQ/NMCCXIM a manufacturer and marketer of medical monitoring equipment, today provided an update on its investment in Immtech International Inc., a leading research company in the area of biotechnology. Immtech's proprietary product,
- Repeat infection found with assay can select women at risk for cervical lesions.
- Newspaper article from: Cancer Vaccine Week February 3, 2003 700+ words
...detecting 13 high-risk human papillomavirus (HR-HPV) types for the screening of cervical lesions, we monitored by cytology, HR-HPV testing, colposcopy and biopsy, in 3...at biopsy. In our population of 659 HR-HPV-infected women, 241 (36,6%) had...
- German Study in the British Journal of Cancer Supports Use of Digene's...
- Press release article from: PR Newswire May 21, 2003 700+ words
...2 High-Risk HPV DNA Test(TM) (hc2 HR HPV DNA Test) for the detection of cervical...in Germany. The combination of the hc2 HR HPV DNA Test and a conventional Pap smear demonstrated...population, when combined with Digene's hc2 HR HPV DNA Test, all disease was detected. In...